Tailored radiation aims to shrink tumors, spare healthy tissue in nasopharyngeal cancer
NCT ID NCT07661771
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial tests whether a personalized radiation plan, which expands the treatment area based on each patient's tumor margins, can control nasopharyngeal cancer as well as the standard approach. The study includes 568 adults with newly diagnosed, non-metastatic disease. Participants receive standard therapy (chemotherapy, immunotherapy, or radiation alone depending on tumor stage) but with either the individualized or standard radiation targeting. The goal is to see if the personalized method maintains local tumor control while possibly reducing complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Individualized radiation therapy (IMRT with personalized target volume)
What this could lead to
If successful, this approach could offer a more precise radiation treatment for nasopharyngeal cancer, potentially reducing side effects while maintaining disease control.
What could go wrong
This is a non-inferiority trial, meaning it aims to show the new method is not worse than the standard. There is a risk it may not be as effective, or benefits may be small.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-METASTATIC NASOPHARYNGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dongguan People's Hospital
Dongguan, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hunan Cancer Hospital
Changsha, Hunan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xiangya Hospital Central South University
Changsha, Hunan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••